Author Question: For which patient would intravenous ibandronate (Boniva) be a better choice of drug therapy for ... (Read 46 times)

Wadzanai · **on:** Jul 23, 2018

For which patient would intravenous ibandronate (Boniva) be a better choice of drug therapy for osteoporosis instead of the oral form of the drug?

a. 66-year-old woman whose osteoporosis is severe has not responded to oral therapy.
b. 64-year-old woman who runs 5 miles daily and has type 2 diabetes mellitus.
c. 70-year-old woman who is undergoing radiation therapy for breast cancer.
d. 58-year-old woman who has early stage Alzheimer's disease.

Question 2

Why are estrogen agonist/antagonists preferred as preventive therapy for osteoporosis instead of pure estrogen agonists?

a. Pure estrogen agonists promote cell growth in the breast and uterus as well as in the bones.
b. Pure estrogen agonists are less effective at balancing osteoclastic and osteoblastic activity.
c. Estrogen agonists/antagonists can be used in both premenopausal women and in women after menopause.
d. Estrogen agonists/antagonists act as estrogen agonists in breast and uterine tissues and act as estrogen antagonists in bones.